Daily news email for February 20, 2012 | Click here for updated news
BioSpace - Breaking News
Gilead Sciences, Inc. Drops as Patients Relapse on Hepatitis C Drug
Acorda Therapeutics Buying Morrisville-based Neuronex Inc. for Up to $35 Million
Roche to Move 90,000 Employees to Roche Apps
GeneLink BioSciences, Inc. Completes Sale of GeneWize Life Sciences, Inc.
Children's Hospital Boston Release: To Understand Chromosome Reshuffling, Look to the Genome's 3D Structure
|
Biotech News - Business Wire
BIO Applauds Sen. Stabenow's Grow It Here, Make It Here Initiative
Suppliers Participating in Comparative Effectiveness Research Program to Determine Safest, Most Efficient Care
Emergent BioSolutions to Present at Cowen and Company Health Care Conference
neuGRID, the European Online Diagnosis Tool for Alzheimer's, Goes Global with outGRID and the ITU
neuGRID, het Europese online diagnosehulpmiddel voor de ziekte van Alzheimer, gaat wereldwijd met outGRID en de ITU
|
Biotech News - PR Newswire
Henry Ford Physician Appointed to Presidential Advisory Group
LifeNet Health is Presenting at the 7th Annual Stem Cell Summit in New York on February 21, 2012
PAREXEL International to Present at Citi Global Healthcare Conference
En Turquie, le TheraSphere® redonne espoir aux patients atteints de cancer du foie
ChromaDex® Announces Management Changes
|
Biotechnology - Moreover
Analysis of Relative Performance in the Biotechnology Industry for Shares of Incyte (INCY, ONXX, ALKS, SPPI, MITI)
Top 5 Companies in the Biotechnology Industry with the Best Relative Performance (CPHD, IMGN, HGSI, SGEN, RIGL)
NIH Translational Center Should Raise All Boats, BIO Says
Immunogen, inc. reports second quarter fiscal year 2012 financial results and provides quarterly update
Biotechnology to be 21st-century industry: Life Tech CEO
|
Burrill Report
Proposed FDA Budget Leans on Industry
Gilead Drops on Poor Clinical Trials Results of Pharmasset Drug
Rusnano Invests in Novel Diagnostics
Despite Cuts, Big Pharma Says It's Still Overstaffed
Amyris Scales Back
|
CenterWatch - Clinical Trials
Sanofi's $20 billion Genzyme buy could fuel a big pharma-biotechnology acquisition trend
New Quintiles initiative saves investigative sites the time, and cost, of patient recruitment advertising
Technology companies adapt interactive video concepts for clinical trial informed consent
CRI buys Lifetree, combining investigative sites on both coasts and across all trial phases
New $1b NIH center will tackle early-stage drug development to ease industry risk of failure
|
